We need stronger evidence for (or against) hepatocellular carcinoma surveillance

被引：30

作者：

Jepsen, Peter ^{[1
,2
,3
]}

West, Joe ^{[3
,4
,5
]}

机构：

[1] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark

[2] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark

[3] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England

[4] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr BRC, Nottingham, England

[5] Univ Nottingham, Nottingham, England

来源：

JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 05期

关键词：

Screening; Prevention; Cancer; Epidemiology; COMPETING RISKS; CIRRHOSIS; LIVER; EPIDEMIOLOGY;

D O I：

10.1016/j.jhep.2020.12.029

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Current guidelines from EASL recommend that most patients with cirrhosis are offered surveillance for hepatocellular carcinoma (HCC), but fewer patients than expected actually receive it. The recommendation is based on observational studies and simulations, not randomised trials. In this opinion piece we argue that a randomised trial of HCC surveillance vs. no surveillance is necessary and feasible, and we believe that clinician and patient participation in HCC surveillance would be better if it were based on trial results demonstrating its value. (c) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：1234 / 1239

页数：6

共 37 条

[1] Analysis of time-to-event for observational studies: Guidance to the use of intensity models [J].

Andersen, Per Kragh ;

Perme, Maja Pohar ;

van Houwelingen, Hans C. ;

Cook, Richard J. ;

Joly, Pierre ;

Martinussen, Torben ;

Taylor, Jeremy M. G. ;

Abrahamowicz, Michal ;

Therneau, Terry M. .

STATISTICS IN MEDICINE, 2021, 40 (01) :185-211

[2] Competing risks in epidemiology: possibilities and pitfalls [J].

Andersen, Per Kragh ;

Geskus, Ronald B. ;

de Witte, Theo ;

Putter, Hein .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (03) :861-870

[3] An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis [J].

Atiq, Omair ;

Tiro, Jasmin ;

Yopp, Adam C. ;

Muffler, Adam ;

Marrero, Jorge A. ;

Parikh, Neehar D. ;

Murphy, Caitlin ;

McCallister, Katharine ;

Singal, Amit G. .

HEPATOLOGY, 2017, 65 (04) :1196-1205

[4] Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status [J].

Audureau, Etienne ;

Carrat, Fabrice ;

Layese, Richard ;

Cagnot, Carole ;

Asselah, Tarik ;

Guyader, Dominique ;

Larrey, Dominique ;

De Ledinghen, Victor ;

Ouzan, Denis ;

Zoulim, Fabien ;

Roulot, Dominique ;

Tran, Albert ;

Bronowicki, Jean-Pierre ;

Zarski, Jean-Pierre ;

Riachi, Ghassan ;

Cales, Paul ;

Peron, Jean-Marie ;

Alric, Laurent ;

Bourliere, Marc ;

Mathurin, Philippe ;

Blanc, Jean-Frederic ;

Abergel, Armand ;

Chazouilleres, Olivier ;

Mallat, Ariane ;

Grange, Jean-Didier ;

Attali, Pierre ;

D'Alteroche, Louis ;

Wartelle, Claire ;

Thong Dao ;

Thabut, Dominique ;

Pilette, Christophe ;

Silvain, Christine ;

Christidis, Christos ;

Nguyen-Khac, Eric ;

Bernard-Chabert, Brigitte ;

Zucman, David ;

Di Martino, Vincent ;

Sutton, Angela ;

Pol, Stanislas ;

Nahon, Pierre .

JOURNAL OF HEPATOLOGY, 2020, 73 (06) :1434-1445

[5] Developing points-based risk-scoring systems in the presence of competing risks [J].

Austin, Peter C. ;

Lee, Douglas S. ;

D'Agostino, Ralph B. ;

Fine, Jason P. .

STATISTICS IN MEDICINE, 2016, 35 (22) :4056-4072

[6] BREAST CANCER SCREENING The NHS breast screening programme needs independent review [J].

Bewley, Susan .

BMJ-BRITISH MEDICAL JOURNAL, 2011, 343

[7]

Cleese J., 2020, creativity: A short and cheerful guide

[8] This Week in the Journal [J].

de Koning, H. J. ;

van der Aalst, C. M. ;

de Jong, P. A. ;

Scholten, E. T. ;

Nackaerts, K. ;

Heuvelmans, M. A. ;

Lammers, J. -W. J. ;

Weenink, C. ;

Yousaf-Khan, U. ;

Horeweg, N. ;

van't Westeinde, S. ;

Prokop, M. ;

Mali, W. P. ;

Hoesein, F. A. A. Mohamed ;

van Ooijen, P. M. A. ;

Aerts, J. G. J. V. ;

den Bakker, M. A. ;

Thunnissen, E. ;

Verschakelen, J. ;

Vliegenthart, R. ;

Walter, J. E. ;

ten Haaf, K. ;

Groen, H. J. M. ;

Oudkerk, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06) :503-513

[9]

European Assoc Study Liver, 2018, J HEPATOL, V69, P154, DOI 10.1016/j.jhep.2018.03.018

[10] aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis [J].

Fan, Rong ;

Papatheodoridis, George ;

Sun, Jian ;

Innes, Hamish ;

Toyoda, Hidenori ;

Xie, Qing ;

Mo, Shuyuan ;

Sypsa, Vana ;

Guha, Indra Neil ;

Kumada, Takashi ;

Niu, Junqi ;

Dalekos, George ;

Yasuda, Satoshi ;

Barnes, Eleanor ;

Lian, Jianqi ;

Suri, Vithika ;

Idilman, Ramazan ;

Barclay, Stephen T. ;

Dou, Xiaoguang ;

Berg, Thomas ;

Hayes, Peter C. ;

Flaherty, John F. ;

Zhou, Yuanping ;

Zhang, Zhengang ;

Buti, Maria ;

Hutchinson, Sharon J. ;

Guo, Yabing ;

Calleja, Jose Luis ;

Lin, Lanjia ;

Zhao, Longfeng ;

Chen, Yongpeng ;

Janssen, Harry L. A. ;

Zhu, Chaonan ;

Shi, Lei ;

Tang, Xiaoping ;

Gaggar, Anuj ;

Wei, Lai ;

Jia, Jidong ;

Irving, William L. ;

Johnson, Philip J. ;

Lampertico, Pietro ;

Hou, Jinlin .

JOURNAL OF HEPATOLOGY, 2020, 73 (06) :1368-1378

← 1 2 3 4 →